{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:49:41Z","timestamp":1791985781235,"version":"4.4.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/jcp.0b013e3181dcb2f3","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T04:28:32Z","timestamp":1273033712000},"page":"290-293","source":"Crossref","is-referenced-by-count":34,"title":["Tapering Clonazepam in Patients With Panic Disorder After at Least 3 Years of Treatment"],"prefix":"10.1097","volume":"30","author":[{"given":"Antonio E.","family":"Nardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael C.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre M.","family":"Valen\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Amrein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Claudia R.","family":"de Cerqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana L.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Mezzasalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 B.","family":"Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Sardinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcele R.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael T.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valfrido L.","family":"de-Melo-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gast\u00e3o L.","family":"Soares-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Versiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","article-title":"The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.","volume":"63","author":"Kessler","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00004714-199812001-00004","article-title":"Panic disorder: long-term pharmacotherapy and discontinuation.","volume":"18","author":"Rickels","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4088\/JCP.v60n0907","article-title":"Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.","volume":"60","author":"Moroz","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00002018-199818060-00003","article-title":"A risk-benefit assessment of pharmacological treatments for panic disorder.","volume":"18","author":"Bennett","year":"1998","journal-title":"Drug Saf"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-0327(90)90009-W","article-title":"The Benzodiazepine Withdrawal Symptom Questionnaire.","volume":"19","author":"Tyrer","year":"1990","journal-title":"J Affect Disord"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00004714-198912000-00005","article-title":"A clinical scale to assess benzodiazepine withdrawal.","volume":"9","author":"Busto","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.","volume":"47","author":"Rickels","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0740-5472(91)90023-4","article-title":"Protracted withdrawal syndromes from benzodiazepines.","volume":"8","author":"Ashton","year":"1991","journal-title":"J Subst Abuse Treat"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2005.05.011","article-title":"A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.","volume":"137","author":"Nardi","year":"2005","journal-title":"Psychiatry Res"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"issue":"suppl 8","key":"R12-12-20210128","first-page":"47","article-title":"Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety.","volume":"59","author":"Ballenger","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine: a review of its use in major depression and other psychiatric disorders.","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"key":"R14-12-20210128","first-page":"166","article-title":"Employing mirtazapine to aid benzodiazepine withdrawal.","volume":"49","author":"Chandrasekaran","year":"2008","journal-title":"Singapore Med J"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000069089","article-title":"Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers.","volume":"49","author":"Crevoisier","year":"2003","journal-title":"Eur Neurol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e3181dcb2f3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:17:47Z","timestamp":1786040267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181dcb2f3","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}